Group AC Meningococcal Polysaccharide Vaccine of Hualan Biological Bacterin Co., Ltd Passing GMP
Shengming Bio is wholly owned subsidiary of Hualan Group and can provide CRO and CMO services related to monoclonal antibody drugs that fully meet the requirements of CFDA/FDA.
Hualan Bio, 2018 CSITF Exhibition, Biological Medicine, Plasma Products, Vaccine Products
Recommended composition of influenza virus vaccines for use in the 2018-2019 northern hemisphere influenza season
According to the latest FluView report, Influenza activity increased again in USA. The overall hospitalization rate is higher than the overall hospitalization rate reported during the same week of the 2014-2015 season; the most severe season in recent years.
More and More People Die of Respiratory Diseases Linked to Seasonal Flu, Inactivated Influenza Vaccine(Split Virion) of Hualan Bio Passed WHO PQ, and Win Great Reputation from UNICEF.
Hualan Biological produces plasma and vaccines more than 25 years, including Human Albumin, IVIG, Human Coagulation Factor VIII, Vaccines and other biological products.
Hualan Bio Attending the 2017 CPhI Worldwide Exhibition with Plasma and Vaccine Products